Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analyst / Institutional Meet on May 23, 2024 with Progressive Shares and Awriga Capital17-05-2024
17-05-2024
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording of the Conference call held today i.e. on Wednesday, May 15, 2024 on the audited Financial Results for the quarter and year ended March 31, 2024, is available on the website of the Company at www.advancedenzymes.com/investors/analyst-corner15-05-2024
Advanced Enzyme Technologies Ltd - 540025 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report of the Company for the year ended March 31, 202415-05-2024
Advanced Enzyme Technologies Ltd - 540025 - Communication To Shareholders - Intimation On Tax Deduction On Dividend
Communication to Shareholders - Intimation on Tax deduction on Dividend . The Company has sent the enclosed email communication to its shareholders whose email addresses are registered with the Depository Participants.13-05-2024
Q4FY24 Quarterly & FY24 Annual Result Announced for Advanced Enzyme Technologies Ltd.
Biotechnology company Advanced Enzyme Technologies announced consolidated Q4FY24 & FY24 results: Q4FY24 Financial Highlights: Revenue from Operations: Revenue from operations on consolidated basis increased to Rs 1,578 million in the Q4FY24 from Rs 1,387 million in the Q4FY23, a growth of 14%. Profit: Consolidated EBITDA during Q4FY24 stands at Rs 554 million as compared to Rs 441 million during Q4FY23, an increase of 26%. Profit before tax stands at Rs 397 million during Q4FY24 as against Rs 421 million in Q4FY23, decrease of 6%. Profit after tax de-grew by 7% and stands at Rs 299 million during Q4FY24 as compared to Rs 321 million during the Q4FY23. Margin: EBITDA margin stands at 35%, PBT margin stands at 25% and PAT margin stood at 19% during the quarter. Financial Costs: Financial costs stood at Rs 8 million during Q4FY24 as against Rs 6 million in Q4FY23. Depreciation and Amortization: Depreciation and Amortization charge for the Q4FY24 stood at Rs 93 million as compared to Rs 84 million, the same quarter previous year. Earnings Per Share: Earnings Per Share during Q4FY24 stands at Rs 2.53 as compared to Rs 2.87 in Q4FY23. FY24 Financial Highlights: Revenue from Operations: Revenue from operations on consolidated basis increased to Rs 6,239 million in the FY24 from Rs 5,406 million in the FY23, reported an increase of 15%. Profit: Consolidated EBITDA during FY24 stands at Rs 2,045 million as compared to Rs 1,546 million during FY23, growth of 31%. Profit before tax stands at Rs 1,879 million during FY24 as against Rs 1,404 million in FY23, an increase of 34% Profit after tax stands at Rs 1,370 million during FY24 as compared to Rs 1,039 million during the FY23, an increase of 32%. Margin: EBITDA margin stands at 33%, PBT margin stands at 30% and PAT margin stands at 22% during the FY24. Financial Costs: Financial costs stood at Rs 29 million during FY24 as against Rs 24 million in FY23. Depreciation and Amortization: Depreciation and Amortization charge for the FY24 is Rs 353 million as compared to Rs 350 million in FY23. Earnings Per Share: Earnings Per Share during FY24 stands at Rs 11.92 as compared to Rs 9.45 in FY23. Result PDF13-05-2024
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of newspaper publication of Extract of audited Consolidated Financial Results for the quarter and year ended March 31, 2024 published in The Free Press Journal and Navshakti on May 12, 202413-05-2024
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015. enclosed is Earning Presentation for the quarter and year ended March 31, 202411-05-2024
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015, enclosed is is Press Release dated May 11, 2024.11-05-2024
Advanced Enzyme Technologies Ltd - 540025 - Corporate Action-Board approves Dividend
Declared an Interim Dividend @ 200% i.e. Rs. 4/- per Equity Share on the Face Value of Rs. 2/- each for the Financial Year 2024-2511-05-2024
Advanced Enzyme Technologies Ltd - 540025 - Audited Financial Statement (Standalone And Consolidated) Of The Company For The Financial Year Ended March 31, 2024
Audited Financial Statement (Standalone and Consolidated)of the Company for the Financial year ended March 31, 202411-05-2024